Stefan Nilsson
CIK 2045818 · President, Nobel Biocare · last filed 2026-08-27
Stefan Nilsson is a President, Nobel Biocare who has filed 4 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider had shares withheld for taxes covering $22.1K of NVST on Aug 27, 2026. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.47M
1
4
$0
Filer Profile
BUILDING E
BREA, CA 92821
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVST | President, Nobel Biocare | 61,560 | $23.95 | $1.47M | $0 | 4 | 2026-08-27 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-27 | NVST | Tax (F) | −804 | -$22.1K | EDGAR |
| 2026-02-27 | NVST | Mixed | +7,423 | -$5.4K | EDGAR |
| 2025-08-27 | NVST | Tax (F) | −804 | -$17.0K | EDGAR |
| 2025-02-27 | NVST | Grant (A) | +10,290 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.